P

Inventor

FOORD ORIT

US78 patents
⚠️ This page may combine multiple inventors who share the name “FOORD ORIT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBVIE STEMCENTRX LLC

12 patents
US11033634B2Jun 15, 2021

Light chain variable regions

ABBVIE STEMCENTRX LLC6 citations93
US10137204B2Nov 27, 2018

Anti-DLL3 antibody drug conjugates for treating cancer

ABBVIE STEMCENTRX LLC8 citations93
US9937268B2Apr 10, 2018

Anti-DLL3 antibody drug conjugates and methods of use

ABBVIE STEMCENTRX LLC9 citations93
US9931421B2Apr 3, 2018

Methods of delivering DLL3 antibody drug conjugates

ABBVIE STEMCENTRX LLC9 citations93
US9931420B2Apr 3, 2018

Methods of making DLL3 antibody drug conjugates

ABBVIE STEMCENTRX LLC9 citations93
US9878053B2Jan 30, 2018

Methods of delivering DLL3 antibody drug conjugates

ABBVIE STEMCENTRX LLC9 citations93
US9867887B1Jan 16, 2018

Anti-DLL3 antibody drug conjugates

ABBVIE STEMCENTRX LLC9 citations93
US9861708B2Jan 9, 2018

Kits containing DLL3 antibody drug conjugates

ABBVIE STEMCENTRX LLC9 citations93
US9855343B2Jan 2, 2018

Anti-DLL3 antibody drug conjugates

ABBVIE STEMCENTRX LLC9 citations93
US9775916B1Oct 3, 2017

Anti-DLL3 antibody drug conjugates for treating cancer

ABBVIE STEMCENTRX LLC9 citations93
US9770518B1Sep 26, 2017

Anti-DLL3 antibody drug conjugates

ABBVIE STEMCENTRX LLC9 citations93
US9764042B1Sep 19, 2017

Methods of making DLL3 antibody drug conjugates

ABBVIE STEMCENTRX LLC9 citations93

STEMCENTRX INC

11 patents
US9486537B2Nov 8, 2016

Anti-DLL3 antibody drug conjugates

STEMCENTRX INC9 citations92
US9480757B2Nov 1, 2016

Anti-DLL3 antibody drug conjugates

STEMCENTRX INC9 citations92
US9358304B1Jun 7, 2016

Methods of making DLL3 antibody drug conjugates

STEMCENTRX INC10 citations92
US9353182B2May 31, 2016

Anti-DLL3 antibodies

STEMCENTRX INC10 citations92
US9352051B1May 31, 2016

Kits containing DLL3 antibody drug conjugates

STEMCENTRX INC10 citations92
US9334318B1May 10, 2016

Multivalent DLL3 antibodies

STEMCENTRX INC11 citations92
US9155803B1Oct 13, 2015

Anti-DLL3 antibody drug conjugates and methods of use

STEMCENTRX INC10 citations92
US9133271B1Sep 15, 2015

Anti-DLL3 antibody drug conjugates and methods of use

STEMCENTRX INC10 citations92
US9345784B1May 24, 2016

Methods of delivering DLL3 antibody drug conjugates

STEMCENTRX INC3 citations84
US9481727B2Nov 1, 2016

Anti-DLL3 antibody drug conjugates

STEMCENTRX INC2 citations74
US9173959B1Nov 3, 2015

Anti-DLL3 antibody drug conjugates

STEMCENTRX INC3 citations74

STEM CENTRX INC

8 patents
US9089615B2Jul 28, 2015

Anti-DLL3 antibodies

STEM CENTRX INC21 citations96
US9089617B2Jul 28, 2015

Anti-DLL3 antibody drug conjugates

STEM CENTRX INC13 citations96
US8986972B2Mar 24, 2015

Nucleic acid encoding DLL3 antibodies

STEM CENTRX INC22 citations96
US9107961B2Aug 18, 2015

Anti-DLL3 antibody drug conjugates for treating cancer

STEM CENTRX INC11 citations92
US9089616B2Jul 28, 2015

Anti-DLL3 antibody drug conjugates and methods of use

STEM CENTRX INC10 citations92
US9090683B2Jul 28, 2015

Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies

STEM CENTRX INC10 citations92
US9676850B2Jun 13, 2017

Anti SEZ6 antibodies and methods of use

STEM CENTRX INC10 citations84
US9534058B2Jan 3, 2017

Anti-CD324 monoclonal antibodies and uses thereof

STEM CENTRX INC10 citations82

AMGEN FREMONT INC

5 patents
US7736644B2Jun 15, 2010

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

AMGEN FREMONT INC77 citations98
US7628986B2Dec 8, 2009

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

AMGEN FREMONT INC119 citations98
US7566772B2Jul 28, 2009

Antibodies against interleukin-1β

AMGEN FREMONT INC72 citations96
US7285269B2Oct 23, 2007

Antibodies directed to tumor necrosis factor

AMGEN FREMONT INC101 citations96
US7964193B2Jun 21, 2011

Antibodies against interleukin-1 β

AMGEN FREMONT INC29 citations91

WEBER RICHARD

3 patents
US9096672B2Aug 4, 2015

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

WEBER RICHARD16 citations92
US9062113B2Jun 23, 2015

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

WEBER RICHARD7 citations83
US9073998B2Jul 7, 2015

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

WEBER RICHARD3 citations73

AMGEN INC

2 patents
US7585500B2Sep 8, 2009

Fully human monoclonal antibodies to IL-13

AMGEN INC36 citations91
US7994302B2Aug 9, 2011

Fully human monoclonal antibodies to IL-13

AMGEN INC8 citations83

ABGENIX INC

1 patent
US7202343B2Apr 10, 2007

Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof

ABGENIX INC78 citations96

FOORD ORIT

1 patent
US9409995B2Aug 9, 2016

PTK7 modulators and methods of use

FOORD ORIT39 citations94

TRELLIS BIOSCIENCE INC

1 patent
US7736648B2Jun 15, 2010

Anti-RSV G protein antibodies

TRELLIS BIOSCIENCE INC13 citations92

BABCOOK JOHN

1 patent
US8604174B2Dec 10, 2013

High affinity fully human monoclonal antibodies to interleukin-8

BABCOOK JOHN30 citations89

TRELLIS BIOSCIENCE LLC

1 patent
US8362215B2Jan 29, 2013

Antibodies immunoreactive with heregulin-coupled HER3

TRELLIS BIOSCIENCE LLC9 citations82

ASTRAZENECA AB

1 patent
US7482434B2Jan 27, 2009

Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof

ASTRAZENECA AB8 citations82

HAMPL JOHANNES

1 patent
US9320812B2Apr 26, 2016

Modulators and methods of use

HAMPL JOHANNES8 citations79

DYLLA SCOTT J

1 patent
US9458231B2Oct 4, 2016

Modulators and methods of use

DYLLA SCOTT J7 citations78

XIAO FENG

1 patent
US8846873B2Sep 30, 2014

Antibodies directed to GPNMB and uses thereof

XIAO FENG9 citations75

Showing the top 50 of 78 patents by PatentIndex Score.